Author:
Saransaari Pirjo,Oja Simo S.
Reference30 articles.
1. Bouchard, R., and Fedida, D., 1995, Closed-and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5. J. Pharmacol. Exp. Ther. 275: 864–876.
2. Doble, A., 1996, The pharmacology and mechanism of action of riluzole. Neurology 47: S233–241.
3. Gibson, G.E., Manger, T., Toral-Barza, L., and Freeman, G., 1989, Cytosolic-free calcium and neurotransmitter release with decreased availability of glucose and oxygen. Neurochem. Res. 14: 437–443.
4. Hamill, O.P., and McBride, D.W. Jr., 1996, The pharmacology of mechanogated membrane ion channels. Pharmacol. Rev. 48: 231–252.
5. Katayama, Y., Kawamata, T., Tamura, T., Becker, D.P., and Tsubokawa, T., 1991, Calcium dependent glutamate release concomitant with massive potassium flux during cerebral ischemia in vivo. Brain Res. 558: 136–140.